• Fast Shipping to 120+ Countries
Cart 0

Tumor Microenvironment and Cancer Immunity

The tumor microenvironment (TME) represents the intricate milieu surrounding a tumor, comprising various cellular and non-cellular components that intricately interact with cancer cells. This dynamic and multifaceted environment exerts a profound influence on tumor progression, metastasis, and response to therapy. The TME is a complex network of immune cells, fibroblasts, blood vessels, extracellular matrix components, and signaling molecules, collectively orchestrating a supportive or inhibitory landscape for the tumor.

Within the TME, specific protein markers play crucial roles in modulating tumor behavior and are often indicative of the immune response, angiogenesis, and extracellular matrix composition.

Some notable protein markers specific to the TME include:

PD-L1 (Programmed Death-Ligand 1): PD-L1 is expressed on the surface of tumor cells and immune cells within the TME. Its interaction with PD-1 on immune cells can suppress the immune response, facilitating immune evasion by the tumor.

TGF-β (Transforming Growth Factor-beta): TGF-β is a multifunctional cytokine in the TME that regulates processes such as cell proliferation, differentiation, and immune response. Its dysregulation contributes to the immunosuppressive nature of the TME.

VEGF (Vascular Endothelial Growth Factor): VEGF is a key protein involved in angiogenesis within the TME. It promotes the formation of new blood vessels, supporting tumor growth and providing a route for metastatic spread.

Granzyme B: Granzyme B is an enzyme released by cytotoxic T cells and natural killer cells within the TME. Its presence reflects the cytotoxic activity of the immune response against tumor cells.

Understanding the intricate interplay between these protein markers and the TME is crucial for developing targeted therapies that aim to manipulate the tumor microenvironment to enhance anti-tumor immune responses or disrupt supportive factors for tumor growth.

Download the "Tumor Microenvironment and Cancer Immunity" white paper:

DOWNLOAD WHITE PAPER
 

Anti-LAMP1 Antibody
Anti-LAMP1 Antibody

Anti-LAMP1 Antibody

AMAb91298
In Stock (10+)
4 311,0 kr
Anti-PROM1 Antibody
Anti-PROM1 Antibody

Anti-PROM1 Antibody

AMAb91494
In Stock (10+)
3 665,0 kr
Anti-VIM Antibody
Anti-VIM Antibody

Anti-VIM Antibody

AMAb90516
In Stock (10+)
3 665,0 kr
Anti-ARG1 Antibody
Anti-ARG1 Antibody

Anti-ARG1 Antibody

AMAb90545
In Stock (10+)
4 311,0 kr
Anti-DES Antibody
Anti-DES Antibody

Anti-DES Antibody

AMAb91302
In Stock (10+)
4 311,0 kr
Anti-PDGFRA Antibody

Anti-PDGFRA Antibody

HPA004947
In Stock (10+)
3 665,0 kr
Anti-PDCD1LG2 Antibody
Anti-PDCD1LG2 Antibody

Anti-PDCD1LG2 Antibody

HPA013411
In Stock (10+)
4 311,0 kr
Anti-IDO1 Antibody
Anti-IDO1 Antibody

Anti-IDO1 Antibody

HPA023072
In Stock (10+)
3 665,0 kr
Anti-PDGFRB Antibody
Anti-PDGFRB Antibody

Anti-PDGFRB Antibody

HPA028499
On demand
3 665,0 kr